Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites (NCT03315910)
🩺 Plain-English Summary (8th-Grade Level)
This study is to help determine the most effective type or combination of treatments to offer patients seeking lung cancer screening who are smokers to help them reduce the number of cigarettes they smoke, or quit smoking. The investigators long term goal is to increase the benefits of lung cancer screening by providing a blue print of best practices for screening sites to deliver tobacco treatment to their patients who are smokers, in a way that does not add burden to screening site staff and increases the chances of patients quitting smoking.
Who can join: Review the eligibility criteria below.
Location: University of Southern California (Data Collection Only) — Los Angeles, California
Age range: 50 Years to 80 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (18 Sites)
- University of Southern California (Data Collection Only) — Los Angeles, California
- John Muir Health — Walnut Creek, California
- WellStar Health System — La Grange, Georgia
- Rush University Medical Center — Chicago, Illinois
- Riverside Healthcare — Kankakee, Illinois
- St. Mary Medical Center, Community Healthcare System — Crown Point, Indiana
- MercyOne Des Moines Medical Center (Data Collection Only) — Des Moines, Iowa
- Maine Medical Center Cancer Institute — Scarborough, Maine
- Henry Ford Hospital (Data collection only) — Detroit, Michigan
- Munson Healthcare — Traverse City, Michigan
- NYU Winthrop Hospital — Mineola, New York
- Memorial Sloan Kettering Cancer Center — New York, New York
- Weill Cornell Medical Center — New York, New York
- Montefiore Medical Center (Data Collection Only) — The Bronx, New York
- Carolinas Healthcare System Blue Ridge — Morganton, North Carolina
- Fairfield Medical Center — Lancaster, Ohio
- Legacy Health — Portland, Oregon
- Temple University — Philadelphia, Pennsylvania
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Smoking Cessation
- Acceptability of Mobile Applications (Apps) to Enhance Smoking Cessation in a Clinical Tobacco Treatment Program - A Pilot Study — Houston, Texas
- Telephone All Nations Breath of Life — Bethlehem, Pennsylvania
- A Randomized Clinical Trial Assessing Smoking Cessation Interventions In Dental Clinic Smokers — New York, New York
- Pharmacist Intervention to Improve Smoking Cessation — Iowa City, Iowa
- Urban and Reservation Implementation of All Nations Breath of Life — Bethlehem, Pennsylvania
- Smoking Cessation Program in the Construction Sector — Miami, Florida
Explore by condition: All Smoking Cessation clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.